Ads
related to: urinary tract infection treatment
Search results
Don't Miss the Dx: Unexplained Renal Symptoms in Young Adult
Medscape· 18 hours agoLearn more with this brief guide to the presentation, differential diagnosis, and management of this...
Planned Parenthood now offers abortion pills via app across Illinois to expand access
Chicago Sun-Times· 4 days agoLooking to expand access to medication abortions in Illinois, Planned Parenthood will allow people...
Patients paid the price as public money flowed to embattled NJ/NY nursing home owners
The Buffalo News· 4 days agoMaria Lindsay’s family thought she was on the path to recovery when the 72-year-old was sent to the...
CEA-CD3 bispecific antibody cibisatamab with or without atezolizumab in patients with CEA-positive...
Nature· 6 days agoCibisatamab is a T-cell bispecific antibody targeting the carcinoembryonic antigen (CEA) on tumor cells and CD3 epsilon chain on T cells. Here the authors report the results of two clinical ...
Inside the Black Market Where People Make Thousands of Dollars Selling Their Poop
Slate· 2 days agoIn late 2023, Alexandra, a 66-year-old retired woman in D.C., was defrosting a piece of human feces...
NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2024 Financial Results and Provides Business...
WRBL Columbus· 6 days agoPositive data from a Phase 2b/3 trial of NRX-101 in Treatment Resistant Bipolar Depression (TRBD); trial demonstrated depression efficacy comparable to standard of care and ...
Understanding Pediatric Bladder Cancer
Healthline· 3 days agoBladder cancer can happen in children, but this is rare overall. Bladder cancer in children is typically not aggressive and is treated with surgery....
Q1 2024 Iterum Therapeutics PLC Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 7 days agoWe believe this sulopenem data we have generated shows that sulopenem would be a safe and effective treatment option. We are encouraged by recent comments from the Director ...
Revelation Biosciences, Inc. (NASDAQ:REVB) to Post Q2 2024 Earnings of ($1.34) Per Share, Roth...
ETF DAILY NEWS· 5 days agoRevelation Biosciences, Inc. (NASDAQ:REVB – Free Report) – Investment analysts at Roth Capital raised their Q2 2024 earnings per share (EPS) estimates for shares of Revelation Biosciences in ...
Cal Poly students tie for most total awards at 38th annual CSU Research Competition
KEYT 3 Santa Barbara· 5 days agoFive Cal Poly student research teams received first- or second-place recognition at the 2024...
